Abstract
BackgroundThe adoptive transfer of chimeric antigen receptor (CAR)-T cells has emerged as a potent immunotherapy against some hematological malignancies but not yet for epithelial-derived solid tumors. One critical issue is...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have